Ethical Considerations When Vulnerable Populations are Subjects in Pragmatic Trials
Description
This Grand Rounds presentation was part of a special series, Ethical & Regulatory Dimensions of Pragmatic Clinical Trials. Emily Largent explains that while it is ethically acceptable and imperative to enroll vulnerable subjects in research, we must also think about their vulnerability in systematic ways so that we know not only what they are vulnerable to but how we can protect them.
Speaker
Emily A. Largent, JD, PhD, RN
Emanuel & Robert Hart Assistant Professor of Medical Ethics and Health Policy
Department of Medical Ethics and Health Policy
University of Pennsylvania Perelman School of Medicine
Related Content
Living Textbook: Data and Safety Monitoring